-
EP2968373
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP2968373
| EP2968373 - COMPOSITIONS AND METHODS FOR TREATING CONDITIONS THAT AFFECT EPIDERMIS [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 01.02.2019 Database last updated on 24.07.2024 | |
| Former | Request for examination was made Status updated on 28.10.2018 | Most recent event Tooltip | 01.02.2019 | Application deemed to be withdrawn | published on 06.03.2019 [2019/10] | Applicant(s) | For all designated states Gencia Corporation 200 Garrett Street Suite H Charlottesville, VA 22902 / US | [2016/03] | Inventor(s) | 01 /
KHAN, Shaharyar 1107 Pike Place Charlottesville, VA 22901 / US | 02 /
ROMERO, Arthur, Glenn 1201 Turnberry Ridge Court Chesterfield, MT 63005 / US | 03 /
HERLEVSEN, Mikael, C. 5575 Jamestown Road Crozet, VA 22932 / US | [2016/03] | Representative(s) | Harris, Jennifer Lucy, et al Kilburn & Strode LLP Lacon London 84 Theobalds Road London WC1X 8NL / GB | [N/P] |
| Former [2016/03] | Harris, Jennifer Lucy, et al Kilburn & Strode LLP 20 Red Lion Street London WC1R 4PJ / GB | Application number, filing date | 14719584.6 | 14.03.2014 | [2016/03] | WO2014US28248 | Priority number, date | US201361788959P | 15.03.2013 Original published format: US 201361788959 P | US201361787844P | 15.03.2013 Original published format: US 201361787844 P | US201361866821P | 16.08.2013 Original published format: US 201361866821 P | US201361895751P | 25.10.2013 Original published format: US 201361895751 P | US201361905631P | 18.11.2013 Original published format: US 201361905631 P | [2016/03] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | WO2014144017 | Date: | 18.09.2014 | Language: | EN | [2014/38] | Type: | A2 Application without search report | No.: | EP2968373 | Date: | 20.01.2016 | Language: | EN | The application published by WIPO in one of the EPO official languages on 18.09.2014 takes the place of the publication of the European patent application. | [2016/03] | Search report(s) | International search report - published on: | EP | 27.11.2014 | Classification | IPC: | A61K31/66, A61P21/00, A61K38/17 | [2016/03] | CPC: |
A61K31/66 (EP,US);
A61K31/4188 (EP,US);
A61K31/573 (EP,US);
A61K31/662 (EP,US);
A61K31/675 (EP,US);
A61K31/7068 (EP,US);
A61K38/1709 (EP,US);
A61K45/06 (EP,US);
A61K8/55 (EP,US);
A61K8/64 (EP,US);
A61P21/00 (EP);
A61Q19/00 (US);
A61Q19/08 (EP,US)
(-)
| C-Set: |
A61K31/4188, A61K2300/00 (US,EP);
A61K31/573, A61K2300/00 (US,EP);
A61K31/662, A61K2300/00 (EP,US);
A61K31/7068, A61K2300/00 (US,EP) | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2016/03] | Title | German: | ZUSAMMENSETZUNGEN UND VERFAHREN ZUR BEHANDLUNG VON ERKRANKUNGEN MIT AUSWIRKUNGEN AUF DIE EPIDERMIS | [2016/03] | English: | COMPOSITIONS AND METHODS FOR TREATING CONDITIONS THAT AFFECT EPIDERMIS | [2016/03] | French: | COMPOSITIONS ET MÉTHODES DE TRAITEMENT D'AFFECTIONS QUI TOUCHENT L'ÉPIDERME | [2016/03] | Entry into regional phase | 29.09.2015 | National basic fee paid | 29.09.2015 | Designation fee(s) paid | 29.09.2015 | Examination fee paid | Examination procedure | 29.09.2015 | Examination requested [2016/03] | 09.05.2016 | Amendment by applicant (claims and/or description) | 02.10.2018 | Application deemed to be withdrawn, date of legal effect [2019/10] | 29.10.2018 | Despatch of communication that the application is deemed to be withdrawn, reason: renewal fee not paid in time [2019/10] | Fees paid | Renewal fee | 10.03.2016 | Renewal fee patent year 03 | 10.03.2017 | Renewal fee patent year 04 | Penalty fee | Additional fee for renewal fee | 31.03.2018 | 05 M06 Not yet paid |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [XDPY]WO2013043580 (GENCIA CORP [US]) [XDP] 1-15,17 * paragraph [0132] - paragraph [0132]; example -; claim -; table 1 * [Y] 1-15,17-38; | [XY]WO2009033130 (GENCIA CORP [US], et al) [X] 1,17-38 * page 13, line 10 - page 17, line 8; compound Ib * * page 28, line 20 - page 30, line 3 * [Y] 1-15,17-38; | [A]WO2010045335 (GENCIA CORP [US], et al) [A] 1-15,17-38 * claim - *; | [AD]US2009208478 (KHAN SHAHARYAR M [US]) [AD] 1-15,17-38 * paragraph [0133] - paragraph [0146]; claim - * | [YD] - FRANK FISCHER ET AL, "Folic acid and creatine improve the firmness of human skin in vivo", JOURNAL OF COSMETIC DERMATOLOGY, (20110321), vol. 10, no. 1, doi:10.1111/j.1473-2165.2010.00543.x, ISSN 1473-2130, pages 15 - 23, XP055127806 [YD] 1-15,17-38 * abstract * DOI: http://dx.doi.org/10.1111/j.1473-2165.2010.00543.x | [Y] - ERIC S. RAWSON ET AL, "Use of creatine in the elderly and evidence for effects on cognitive function in young and old", AMINO ACIDS, (20110311), vol. 40, no. 5, doi:10.1007/s00726-011-0855-9, ISSN 0939-4451, pages 1349 - 1362, XP055128902 [Y] 1-15,17-38 * abstract * DOI: http://dx.doi.org/10.1007/s00726-011-0855-9 | [Y] - PERSKY A M ET AL, "CLINICAL PHARMACOLOGY OF THE DIETARY SUPPLEMENT CREATINE MONOHYDRATE", PHARMACOLOGICAL REVIEWS, AMERICAN SOCIETY FOR PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, US, (20010101), vol. 53, no. 2, ISSN 0031-6997, pages 161 - 176, XP008057558 [Y] 1-15,17-38 * page 170 - page 172 * | [Y] - MURPHY MICHAEL P ET AL, "Targeting antioxidants to mitochondria by conjugation to lipophilic cations", ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, ANNUAL REVIEW INC., PALO ALTO, CA, US, (20070101), vol. 47, doi:10.1146/ANNUREV.PHARMTOX.47.120505.105110, ISSN 0362-1642, pages 629 - 656, XP009109550 [Y] 1-15,17-38 * figures 2-5 * DOI: http://dx.doi.org/10.1146/annurev.pharmtox.47.120505.105110 | by applicant | US2005147993 | US8039587 | US4925673 | US5013556 | WO2013043580 | US8062891 | US8133733 | US2009123468 | US2009208478 | US2006211647 | US2008095834 | US2007275924 | US6156337 | US7060461 | US6872551 | - FARAGE, MIRANDA A. ET AL., "Clinical implications of aging skin: cutaneous disorders in the elderly", AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, (2009), vol. 10.2, pages 73 - 86 | - JUHN, MARK S.; MAEK TARNOPOLSKY, "Oral creatine supplementation and athletic performance: a critical review", CLINICAL JOURNAL OF SPORT MEDICINE: OFFICIAL JOURNAL OF THE CANADIAN ACADEMY OF SPORT MEDICINE, (1998), vol. 8.4, page 286 | - MCMORRIS, TERRY ET AL., "Creatine supplementation and cognitive performance in elderly individuals", AGING, NEUROPSYCHOLOGY, AND COGNITION, (2007), vol. 14.5, pages 517 - 528 | - FISCHER, FRANK ET AL., "Folic acid and creatine improve the firmness of human skin in vivo", JOURNAL OF COSMETIC DERMATOLOGY, (2011), vol. 10.1, doi:doi:10.1111/j.1473-2165.2010.00543.x, pages 15 - 23, XP055127806 DOI: http://dx.doi.org/10.1111/j.1473-2165.2010.00543.x | - KNOTT, ANJA ET AL., "A novel treatment option for photoaged skin", JOURNAL OF COSMETIC DERMATOLOGY, (2008), vol. 7.1, pages 15 - 22 | - SHAMBAN, AVA T, "Current and new treatments of photodamaged skin", FACIAL PLASTIC SURGERY, (2009), vol. 11.5, page 337 | - BERNEBURG, MARK ET AL., "Creatine supplementation normalizes mutagenesis of mitochondrial DNA as well as functional consequences", JOURNAL OF INVESTIGATIVE DERMATOLOGY, (2005), vol. 125.2, pages 213 - 220 | - SEGAERT, SIEGFRIED, AND ERIC VAN CUTSEM, "Clinical signs, pathophysiology and management of skin toxicity during therapy with epidermal growth factor receptor inhibitors", ANNALS OF ONCOLOGY, vol. 16, no. 9, pages 1425 - 1433 | - AGERO, ANNA LIZA C. ET AL., "Dermatologic side effects associated with the epidermal growth factor receptor inhibitors", JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, (2006), vol. 55.4, doi:doi:10.1016/j.jaad.2005.10.010, pages 657 - 670, XP005660019 DOI: http://dx.doi.org/10.1016/j.jaad.2005.10.010 | - Remington's Pharmaceutical Sciences, 20th ed., LIPPINCOTT WILLIAMS & WILKINS, (2000), page 704 | - KOLOMEITSEV ET AL., TET. LETT., (2003), vol. 44, no. 33, pages 5795 - 5798 | - ASIN-CAYUELA ET AL., FEBS LETT., (2004), vol. 571, no. 1-3, pages 9 - 16 | - KABOURIDIS, P., TRENDS IN BIOTECHNOLOGY, (2003), pages 498 - 503 | - FRANKEL; PABO, CELL, (1988), vol. 55, no. 6, pages 1189 - 93 | - DEROSSI ET AL., J BIOL CHEM., (1994), vol. 269, no. 14, pages 10444 - 50 | - YOUSIF ET AL., CHEMBIOCHEM., (2009), vol. 10, no. 13, page 2131 | - HORTON ET AL., CHEM BIOL., (2008), vol. 15, no. 4, pages 375 - 82 | - YOUSIF ET AL., CHEMBIOCHEM.,, (2009), vol. 10, no. 13, page 2131 | - DEL GAIZO ET AL., MOL GENET METAB., (2003), vol. 80, no. 1-2, pages 170 - 80 | - FINK ET AL., CRIT. CARE. MED., (2007), vol. 35, pages S461 - 7 | - FRANTZ; WIPF, ENVIRON MOL MUTAGEN., (2010), vol. 51, no. 5, pages 462 - 475 | - GALLEY, CRIT CARE, (2010), vol. 14, no. 4, pages 230,1 - 9 | - CARILLO, H.; LIPMAN, D., SIAM J APPLIED MATH., (1988), vol. 48, page 1073 | - NEEDELMAN; WUNSCH, J. MOL. BIOL., (1970), vol. 48, pages 443 - 453 | - WAGNER ET AL., ADV GEN, (2005), vol. 53, pages 333 - 354 | - RAE ET AL., PROC. R. SOC. LOND., (2007), vol. 270, pages 2147 - 2150 | - "Chapter 89", Remington's Pharmaceutical Sciences, 18th Ed., MACK PUBLISHING CO., (1990), page 18042 | - ABUCHOWSKI; DAVIS, "Soluble Polymer-Enzyme Adducts", ABUCHOWSKI; DAVIS, HOCENBERG AND ROBERTS, Enzymes as Drugs, WILEY-INTERSCIENCE, (1981), pages 367 - 383 | - NEWMARK ET AL., J. APPL. BIOCHEM., (1982), vol. 4, pages 185 - 189 | - DAIRAGHI ET AL., J. MOL. BIOL., (1995), vol. 249, pages 11 - 28 | - MATSUSHIMA ET AL., J. BIOL. CHEM., (2003), vol. 278, no. 33, pages 31149 - 31158 | - GANGELOFF ET AL., NUCL. ACID. RES., (2009), vol. 37, no. 10, pages 3153 - 3164 | - SANDERMAN, K. ET AL., CELL. MOL. LIFE SCI., (1998), vol. 54, pages 1350 - 1364 | - WENDER ET AL., PROC NATL ACAD SCI USA., (2000), vol. 97, no. 24, pages 13003 - 8 | - HO ET AL., CANCER RES., (2001), vol. 61, no. 2, pages 474 - 7 | - WADIA ET AL., NATURE MEDICINE, (2004), vol. 10, pages 310 - 315 | - BARKA ET AL., J. HISTOCHEM. CYTOCHEM., (2000), vol. 48, no. 11, pages 1453 - 60 | - YOUSIF ET AL., CHEMBIOCHEM, (2009), vol. 10, no. 13, page 2131 | - MALAKHOV ET AL., J. STRUCT. FUNCT. GENOMICS, (2004), vol. 5, pages 75 - 86 | - ZUO ET AL., J. STRUCT. FUNCT. GENOMICS, (2005), vol. 6, pages 103 - 111 | - SYNTHESIS, (1989), page 301 | - SYNTHESIS, (1989), vol. 301 | - BULL. CHIM. SOC. FR., (1985), page 980 | - SCHOEPE S; SCHACKE H; BERND A; ZOLLER N; ASADULLAH K, "Identification of novel in vitro test systems for the determination of glucocorticoid receptor ligand-induced skin atrophy", SKIN PHARMACOL PHYSIOL., (20091223), vol. 23, no. 3, pages 139 - 51 | - ZOLLER NN; KIPPENBERGER S; THACI D; MEWES K; SPIEGEL M; SATTLER A; SCHULTZ M; BEREITER-HAHN J; KAUFMANN R; BERND A, "Evaluation of beneficial and adverse effects of glucocorticoids on a newly developed full-thickness skin model", TOXICOL IN VITRO, (20080204), vol. 22, no. 3, doi:doi:10.1016/j.tiv.2007.11.022, pages 747 - 59, XP022511912 DOI: http://dx.doi.org/10.1016/j.tiv.2007.11.022 |